Expression of the dmrt1 and vtg genes was described using the real-time PCR (rt-PCR) method from 25 to 1600 days post-hatch (dph) in cultured Russian sturgeon Acipenser gueldenstaedtii. The level of dmrt1 transcription in gonads in subsequent studied periods increased exponentially while vtg expression increased in gonads and livers of A. gueldenstaedtii examined, but in later stages of development. Both dmrt1 and vtg genes showed elevated expression in intersex individuals probably caused by dietary exposure to phyto-oestrogens.

Sex determination is a complex process, especially in fish where multiple models of sex determination can be identified. The fate of differentiating gonads may depend on species genetics, environmental or behavioural factors. In the case of the sturgeon, sex determination is most likely of genetic origin and is characterized by a ZW female heterogametic system. However, molecular mechanisms of sex development and differentiation in sturgeons are poorly understood. Due to the lack of sexual dimorphism and a long period of maturation combined with invaluable caviar obtained from sturgeons, plenty of research revolving around discovering master sex‐determining gene has been done. Yet, despite numerous studies utilizing multiple approaches and techniques to find key genes involved in sex differentiation, no master sex‐determining genes were identified in sturgeons. Nevertheless, the latest research provided a great deal of data regarding the expression of genes commonly related with sex development and differentiation in vertebrates. Several of these genes were found to be connected with the same processes in sturgeons. This review attempts to summarize research into the expression of genes involved in sex differentiation and development in sturgeons.

No abstract

A common global trend in modern aquaculture is to reduce or replace fishmeal in fish diets with alternative protein sources, mainly from protein‐rich plants such as soybean; however, plant‐based aquafeeds are a source of substantial amounts of phytoestrogens. Phytoestrogens belong to endocrine‐disrupting chemicals (EDCs) which can negatively interfere with fish reproduction; thus, they should be avoided in sturgeon diet. Therefore, the aim of the study was to evaluate concentrations and the profile of dietary isoflavone phytoestrogens in the two commercial sturgeon diets. A substantial amount of isoflavones, reaching in total from 1.5 to 50 mg/kg of feed, were found in analysed diets. Genistein and daidzein, which are typical constituents of soybean, were the most abundant phytoestrogens in the analysed feeds. Equol, the third most abundant phytoestrogen in the tested samples, was originated most probably from animal components. Additionally, the accumulation of dietary isoflavones in the liver, blood and gonads of two commonly farmed sturgeon species (Acipenser gueldenstaedtii and Acipenser baerii) after long‐term dietary exposure was also assessed. Significant concentrations of isoflavones were found in liver and blood samples of both sturgeon species at 600th and 800th dph, indicating high accumulation of these compounds, which may lead to endocrine disturbance.

The effects of CEME and it complex with GO injected in ovo on the growth and development of chicken embryo hindlimb muscle were investigated. First, the preliminary in vitro study on primary muscle precursor cell culture obtained from a nine-day-old chicken embryo was performed to assess toxicity (MTT assay) of CEME, GO (100 ppm) and it complex with different concentrations (1, 2, 5, and 10 wt.%). The effect on cell proliferation was investigated by BrdU assay. CEME at concentrations 1–5% increased cell proliferation, but not the complex with GO. In vitro cytotoxicity was highest in 10% and GO groups. Next, the main experiment with chicken embryos was performed with CEME, GO and it complex injected in ovo on day one of embryogenesis. On day 20 of embryogenesis survival, morphological development, histological structure of the muscle, and biochemical parameters of blood serum of the embryos were measured. No negative effect on mortality, body weight, or biochemistry of blood after use of CEME or GO-CEME complexes was observed. Interestingly, the slight toxicity of GO, observed in in vitro studies, was not observed in vivo. The use of CEME at the levels of 2% and 5% improved the structure of the lower limb muscle by increasing the number of cells, and the administration of 2% CEME increased the number of nuclei visible in the stained cross-section of the muscle. The complex GO-CEME did not further improve the muscle structure. The results indicate that CEME can be applied as an in ovo enhancer of muscle development in broilers.